
Sun Pharma Shares: SEBI RA Spots Buy-On-Dip Opportunity As Stock Holds ₹1,600 Support
After slipping earlier in June, Sun Pharma is regaining traction, backed by steady fundamentals and signs of renewed technical momentum. Shares of Sun Pharmaceutical Industries are showing signs of strength after bouncing back from a recent dip. SEBI- …